The University of Southampton
University of Southampton Institutional Repository

TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway

TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway
TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway
TNF-alpha expression is elevated in a variety of neuropathologies, including multiple sclerosis, cerebral malaria and HIV encephalitis. However, the consequences of such high cerebral TNF-alpha expression remain unresolved. Here, using MRI, we demonstrate that a focal intrastriatal injection of TNF-alpha causes a significant, acute reduction (15-30%) in cerebral blood volume (CBV), which is dependent on TNF-alpha-type 2 receptor (TNFR2) activation, and can be ameliorated by pre-treatment with a non-specific endothelin (ET) receptor antagonist. An acute breakdown of the blood-cerebrospinal fluid barrier (B-CSF-B) and a delayed breakdown of the blood-brain barrier (BBB) were also observed using contrast-enhanced MRI. Furthermore, a significant reduction in tissue water diffusion was apparent 24 h after intrastriatal injection of TNF-alpha injection, which may indicate compromise of tissue energy metabolism. Prolonged expression of endogenous TNF-alpha, achieved through the use of an adenoviral vector expressing TNF-alpha cDNA (Ad5TNF-alpha(m)), caused a sustained depression in CBV in accordance with the single TNF-alpha bolus data. These findings identify vasoconstriction, disrupted tissue homeostasis and damage to the BBBs as adverse effects of TNF-alpha within the brain, and suggest that antagonists of the endothelin and TNF-alpha type 2 receptors may be therapeutic in TNF-alpha-associated neuropathologies.
0006-8950
2446-2459
Sibson, N.R.
f693789d-e7ce-4323-b26a-86cef623120b
Blamire, A.M.
44424cc8-eb88-45dd-910c-f5befb07945e
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
Gauldie, J.
97a5c632-0e54-4360-ac0d-4786155bf375
Styles, P.
9df179d2-0db7-4ae1-998f-db2a265fabe6
Anthony, D.C.
70fb8e27-4e74-4c72-b1b5-3a4ca0d6b8cf
Sibson, N.R.
f693789d-e7ce-4323-b26a-86cef623120b
Blamire, A.M.
44424cc8-eb88-45dd-910c-f5befb07945e
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
Gauldie, J.
97a5c632-0e54-4360-ac0d-4786155bf375
Styles, P.
9df179d2-0db7-4ae1-998f-db2a265fabe6
Anthony, D.C.
70fb8e27-4e74-4c72-b1b5-3a4ca0d6b8cf

Sibson, N.R., Blamire, A.M., Perry, V.H., Gauldie, J., Styles, P. and Anthony, D.C. (2002) TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain, 125 (11), 2446-2459.

Record type: Article

Abstract

TNF-alpha expression is elevated in a variety of neuropathologies, including multiple sclerosis, cerebral malaria and HIV encephalitis. However, the consequences of such high cerebral TNF-alpha expression remain unresolved. Here, using MRI, we demonstrate that a focal intrastriatal injection of TNF-alpha causes a significant, acute reduction (15-30%) in cerebral blood volume (CBV), which is dependent on TNF-alpha-type 2 receptor (TNFR2) activation, and can be ameliorated by pre-treatment with a non-specific endothelin (ET) receptor antagonist. An acute breakdown of the blood-cerebrospinal fluid barrier (B-CSF-B) and a delayed breakdown of the blood-brain barrier (BBB) were also observed using contrast-enhanced MRI. Furthermore, a significant reduction in tissue water diffusion was apparent 24 h after intrastriatal injection of TNF-alpha injection, which may indicate compromise of tissue energy metabolism. Prolonged expression of endogenous TNF-alpha, achieved through the use of an adenoviral vector expressing TNF-alpha cDNA (Ad5TNF-alpha(m)), caused a sustained depression in CBV in accordance with the single TNF-alpha bolus data. These findings identify vasoconstriction, disrupted tissue homeostasis and damage to the BBBs as adverse effects of TNF-alpha within the brain, and suggest that antagonists of the endothelin and TNF-alpha type 2 receptors may be therapeutic in TNF-alpha-associated neuropathologies.

This record has no associated files available for download.

More information

Published date: 1 November 2002

Identifiers

Local EPrints ID: 56074
URI: http://eprints.soton.ac.uk/id/eprint/56074
ISSN: 0006-8950
PURE UUID: c3ad2869-d94d-47ab-ada8-1e670a9c5077

Catalogue record

Date deposited: 07 Aug 2008
Last modified: 22 Jul 2022 21:06

Export record

Contributors

Author: N.R. Sibson
Author: A.M. Blamire
Author: V.H. Perry
Author: J. Gauldie
Author: P. Styles
Author: D.C. Anthony

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×